Vironova is building a state of the art electron microscopy (EM) facility to meet increasing demand
Vironova has established a growing number of global customers in the highly-regulated and quality demanding pharmaceutical industry, who focus on drug/gene delivery and vaccine development. Currently 7 of the 10 largest biopharmaceutical companies are clients to Vironova.
The new EM facility with a BSLII laboratory for sample preparation will greatly increase current capacity and meet the increasing demand for nanoparticle characterization services that the company provides. These are performed using TEM and the proprietary image analysis software VAS (Vironova Analyzer Software) in accordance with GMP, which is essential for applications in pharmaceutical development. Several Microscopists are being recruited for the new lab, which will be finalized during this year.